Allianz Asset Management Gmb H Applied Genetic Technologies Corp Transaction History

Allianz Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2017 Aug 14, 2017	SELL	N/A	-40,820 Closed	0 $0
Q1 2017 Apr 17, 2019	BUY	N/A	3,945 Added 10.7%	40,820 $282,000
Q4 2016 Apr 17, 2019	SELL	N/A	-41,765 Reduced 53.11%	36,875 $345,000
Q3 2016 Apr 17, 2019	BUY	N/A	78,640	78,640 $769,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.